Pediatrics

Positive trial results for RSV infant treatment: Sanofi

French pharmaceutical giant Sanofi announced trial results on Friday that showed its preventative treatment for respiratory syncytial virus (RSV) reduced the rate of babies being hospitalized by more than 80 percent.

Vaccination

EU watchdog backs Sanofi COVID booster jab

The EU on Thursday approved a COVID booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.

page 1 from 13